Calling on Governments to Waive Patents on COVID-19 Vaccines
Leena Menghaney, Regional Head (South Asia), Médecins Sans Frontières Access Campaign
You can share this podcast by copying this HTML to your clipboard and pasting into your blog or web page.
Last month, India and South Africa led several countries in calling for patents and other intellectual properties related to COVID-19 to be waived during the pandemic. While the movement has gained traction through recent talks, many notable countries have said “no”. So is such a waiver necessary or important to better tackle the pandemic?
Image Source: Shutterstock
Produced by: Lim Sue Ann
Presented by: Juliet Jacobs, Lim Sue Ann, Dashran Yohan
This and more than 60,000 other podcasts in your hand. Download the all new BFM mobile app.
Tags: The Bigger Picture, The Daily Digest, COVID-19, Vaccine, Intellectual Property, Patent, Waiver, World Trade Organisation, World Intellectual Property Organisation (WIPO), Trade-Related Aspects of Intellectual Property Rights (TRIPS Agreement), COVAX, Médecins Sans Frontières, Doctors Without Borders, Pharmaceutical Companies,